Drugs / methildopa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01361425 | May 2011 → May 2012 | preeclampsia | Professor Fernando Figueira Integral Medicine Institute | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | methildopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01361425 ↗ |
| Route | Oral | “methildopa, 1,5g/day (500mg 8/8 hours, orally)” NCT01361425 ↗ |